My NCBISign In
Alzheimer's disease therapeutic research: the path forward
Paul S Aisen
Alzheimers Res Ther. 2009; 1(1): 2. Published online 2009 July 9. doi: 10.1186/alzrt2
PMCID:
PMC2719107
Abstract Full Text PDF–67K

Is Cited by the Following 10 Articles in this Archive:

Clinical trial methodologies for disease-modifying therapeutic approaches
Paul S. Aisen
Neurobiol Aging. Author manuscript; available in PMC 2012 December 1.
Published in final edited form as: Neurobiol Aging. 2011 December; 32(Suppl 1): S64–S66. Published online 2011 October 8. doi: 10.1016/j.neurobiolaging.2011.09.008
PMCID:
PMC3232303
Free in PMC on 2012/12/01
A phase 2 randomized trial of ELND005, scyllo-inositol, in mild to moderate Alzheimer disease
S. Salloway, R. Sperling, R. Keren, A.P. Porsteinsson, C.H. van Dyck, P.N. Tariot, S. Gilman, D. Arnold, S. Abushakra, C. Hernandez, G. Crans, E. Liang, G. Quinn, M. Bairu, A. Pastrak, J.M. Cedarbaum, For the ELND005-AD201 Investigators
Neurology. 2011 September 27; 77(13): 1253–1262. doi: 10.1212/WNL.0b013e3182309fa5
PMCID:
PMC3179648
Free in PMC on 2012/09/27
Vanishing clinical psychopharmacology
Joop van Gerven, Adam Cohen
Br J Clin Pharmacol. 2011 July; 72(1): 1–5. doi: 10.1111/j.1365-2125.2011.04021.x
PMCID:
PMC3141181
Free in PMC on 2012/07/01
Biomarkers in AD drug development: can't live without ‘em
Paul S. Aisen
Alzheimers Dement. Author manuscript; available in PMC 2012 May 1.
Published in final edited form as: Alzheimers Dement. 2011 May 1; 7(3): e48–e50. doi: 10.1016/j.jalz.2010.06.006
PMCID:
PMC3116239
Full Text PDF–809K
Alzheimer’s Disease: The Challenge of the Second Century
David M. Holtzman, C. Morris John, Alison Goate
Sci Transl Med. Author manuscript; available in PMC 2012 April 6.
Published in final edited form as: Sci Transl Med. 2011 April 6; 3(77): 77sr1. doi: 10.1126/scitranslmed.3002369
PMCID:
PMC3130546
Abstract Full Text PDF–2.5M
For debate: substituting placebo controls in long-term Alzheimer's prevention trials
René Spiegel, Manfred Berres, André R Miserez, Andreas U Monsch
Alzheimers Res Ther. 2011; 3(2): 9. Published online 2011 March 21. doi: 10.1186/alzrt68
PMCID:
PMC3226271
Abstract Full Text PDF–401K
Report of the task force on designing clinical trials in early (predementia) AD
P.S. Aisen, S. Andrieu, C. Sampaio, M. Carrillo, Z.S. Khachaturian, B. Dubois, H.H. Feldman, R.C. Petersen, E. Siemers, R.S. Doody, S.B. Hendrix, M. Grundman, L.S. Schneider, R.J. Schindler, E. Salmon, W.Z. Potter, R.G. Thomas, D. Salmon, M. Donohue, M.M. Bednar, J. Touchon, B. Vellas
Neurology. 2011 January 18; 76(3): 280–286. Published online 2010 December 22. doi: 10.1212/WNL.0b013e318207b1b9
PMCID:
PMC3034393
Abstract Full Text PDF–304K
Advances in quantitative magnetic resonance imaging-based biomarkers for Alzheimer disease
Bradford C Dickerson
Alzheimers Res Ther. 2010; 2(4): 21. Published online 2010 July 6. doi: 10.1186/alzrt45
PMCID:
PMC2949587
Abstract Full Text PDF–137K
Clinical core of the Alzheimer's Disease Neuroimaging Initiative: progress and plans
PS Aisen, RC Petersen, M Donohue, A Gamst, R Raman, RG Thomas, S Walter, JQ Trojanowski, L Shaw, LA Beckett, CR Jack, W Jagust, A Toga, AJ Saykin, JC Morris, MW Weiner, Alzheimer's Disease Neuroimaging Initiative
Alzheimers Dement. Author manuscript; available in PMC 2011 May 1.
Published in final edited form as: Alzheimers Dement. 2010 May; 6(3): 239–246. doi: 10.1016/j.jalz.2010.03.006
PMCID:
PMC2867843
Abstract Full Text PDF–486K
Cognition, glucose metabolism and amyloid burden in Alzheimer’s disease
Ansgar J. Furst, Gil D. Rabinovici, Ara H. Rostomian, Tyler Steed, Adi Alkalay, Caroline Racine, Bruce L. Miller, William J. Jagust
Neurobiol Aging. Author manuscript; available in PMC 2013 February 1.
Published in final edited form as: Neurobiol Aging. 2012 February; 33(2): 215–225. Published online 2010 April 24. doi: 10.1016/j.neurobiolaging.2010.03.011
PMCID:
PMC2920373
Free in PMC on 2013/02/01
You are here: NCBI > Literature > PubMed Central (PMC)
Write to the Help Desk